Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Drug Discovery Today. Technologies|July 2, 2014
Questions and answers about the Pilot Process for Biomarker Qualification at the FDAFederico M Goodsaid, Felix W FruehPersonalized Medicine|May 24, 2018
Pharmacogenomics steps toward personalized medicineHong-Guang Xie, Felix W FruehDrug Discovery Today. Technologies|July 2, 2014
The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical PathFederico M Goodsaid, Felix W Frueh, William MattesToxicology|February 19, 2008
Strategic paths for biomarker qualificationFederico M Goodsaid, Felix W Frueh, William MattesJournal of Personalized Medicine|January 7, 2015
Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing InformationEric J Stanek, Christopher L Sanders, Felix W FruehBiomarkers in Medicine|May 19, 2010
Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspectiveShashi Amur, Felix W Frueh, Lawrence J Lesko, et al.Journal of Diabetes Science and Technology|October 16, 2013
Diabetes technology, innovation, and the U.S. health insurance systemBruce QuinnPharmacogenomics|December 24, 2008
4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007Felix W Frueh, Ronald A Salerno, Lawrence J Lesko, et al.Nature Reviews. Genetics|June 2, 2011
The future of direct-to-consumer clinical genetic testsFelix W Frueh, Henry T Greely, Robert C Green, et al.Pageof 5